Joshua B. Cohen, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 30,464 shares at $32.16 ($981K) on 2026-09-10, disclosed to the SEC on 2026-09-14.
Open-market sale of $981k AMLX by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.16 | 29,545 | $950K | 96.9% |
| 2 | $33.15 | 919 | $30K | 3.1% |
| Total | $32.19 avg | 30,464 | $981K | 100% |
| Filing → |
| AMLX | SELL | 2026-01-20 | $1.9M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $856K | — | Filing → |